Now Live: Cboe Europe real-time data for all major European stocks.
opens in 6h 33m
Market closed

Pre-market opens in 1 hour 3 minutes
Main market opens in 6 hours 33 minutes

02:56
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
120.86000 CHF
1.04
0.87%
Last update Mar 31, 5:19 PM CEST
Market closed
Day range
120.60000
122.22000
Previous close
119.82000
Open
121.30000
Access this stock data via API
Subscribe
Novartis AG
120.86
1.04
0.87%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Novartis AG is a Swiss multinational pharmaceutical corporation headquartered in Basel, one of the world's largest manufacturers of innovative medicines. Formed in 1996 through the historic merger of Ciba-Geigy and Sandoz, it originated from pioneering Swiss chemical firms dating back to the late 19th century, known for breakthroughs like DDT's insecticidal properties and early pharmaceuticals. In 2023, Novartis restructured by spinning off its generics division, Sandoz, to concentrate on the Innovative Medicines division, focusing on cutting-edge therapeutic areas including oncology, immunology, cardiovascular-renal-metabolic diseases, neuroscience, rare diseases, and ophthalmology. The company employs advanced modalities such as biotherapeutics, gene and cell therapies, radioligand therapy, and xRNA therapeutics, with a robust pipeline featuring late-stage programs and partnerships in AI-driven drug discovery and molecular glues. Novartis operates in approximately 140 countries, reaching millions of patients with key products like Gleevec for leukemia, Entresto for heart failure, Cosentyx for psoriasis, and Kymriah for leukemia via CAR-T therapy. Through its Novartis Institutes for BioMedical Research, it drives global R&D efforts, significantly influencing the pharmaceutical industry's innovation landscape.

About

CEO
Mr. Ahmed Khaled El-Hoshy
Employees
75267
Address
Lichtstrasse 35
11 Bermudiana Road
Basel, 4056, MI
Switzerland
Phone
41 61 324 11 11
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
Switzerland
MIC code
XSWX
Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Feb 20, 2025
BMO Expands Canadian Depositary Receipt (CDR) Lineup with 10 New Listings from Europe and Japan

BMO's CDRs offer enhanced portfolio diversification opportunities for Canadian investors enabling them to hold shares in international companies that trade on a Canadian exchange in Canadian dollars

TORONTO, Feb. 20, 2025 /CNW/ - Bank of Montreal (BMO) announced 10 new CDRs will begin trading on the Cboe Canada exchange today. The initial offering of these new CDRs has closed.

BMO's new CDRs will trade under the following tickers:

Company Name

CDR Ticker

Jurisdiction

Novo Nordisk A/S

NVON

Denmark

SAP SE

SAPG

Germany

ASML Holding NV

ASMH

Netherlands

CIE Financiere Richemont AG

RCHM

Switzerland

Novartis AG

NOVN

Switzerland

Roche Holdings AG

ROCH

Switzerland

UBS Group AG

UBS

Switzerland

Mitsubishi Corp.

MTSU

Japan

Mitsubishi UFJ Financial Group

MUFG

Japan

Softbank Group Corp.

SFTB

Japan

For more information on BMO's CDRs, please visit www.bmocdrs.com.

This material is for information purposes only. The information contained herein is not, and should not be construed as, investment, tax or legal advice to any party.

An investment in CDRs issued by BMO may not be suitable for all investors. Important information about these investment products is contained in the short form base shelf prospectus and prospectus supplement for each series of CDRs (together, the "Prospectus"). Purchasers are directed to www.sedarplus.ca or to www.bmogam.com to obtain copies of the Prospectus and related disclosure before purchasing CDRs of a particular series. The information contained herein is not a recommendation to purchase these investment products.

Each series of CDRs relates to a single class of equity securities (the "Underlying Shares") of an issuer incorporated outside of Canada (the "Underlying Issuer"). For each series of CDRs, the Prospectus will provide additional information regarding such series, including information regarding the Underlying Issuer and Underlying Shares for such series. Neither BMO and its affiliates nor any other person involved in the distribution of CDRs accepts any responsibility for any disclosure provided by any Underlying Issuer (including information contained herein or in the Prospectus that has been extracted from any Underlying Issuer's publicly disseminated disclosure). Each series of CDRs is only offered to investors in Canada in accordance with applicable laws and regulatory requirements.

 "BMO (M-bar roundel symbol)" is a registered trademark of Bank of Montreal, used under licence.

About BMO Financial Group

BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.41 trillion as of October 31, 2024. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society. 

SOURCE BMO Financial Group

Access /press_releases data via our API — starting from the Basic plan and above.
Market closed

Exchange is currently closed
Main market opens in 3 minutes

08:56
00:00
09:00
17:20
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:20
Post-market
18:15 - 22:00
All times are displayed in the Europe/Zurich timezone (CEST, UTC+02:00).